BRITISH JOURNAL OF CANCER Journal
Overview
publication venue for
- A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer. 124:1803-1808. 2021
- Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans. 116:688-696. 2017
- The impact of age on complications, survival, and cause of death following colon cancer surgery. 116:389-397. 2017
- Fruit and vegetable consumption in relation to hepatocellular carcinoma in a multi-centre, European cohort study. 112:1273-1282. 2015
- Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial. 108:1021-1026. 2013
- Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer. 101:1543-1548. 2009
- In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. 96:1587-1594. 2007
- Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. 84:1443-1446. 2001
- Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. 83:1425-1431. 2000
- Vascular endothelial growth factor in premenopausal women - indicator of the best time for breast cancer surgery?. 78:1203-1207. 1998
- INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA MAY BE RESPONSIBLE FOR THE LYTIC MECHANISM DURING ANTITUMOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY. 72:601-606. 1995
- M17-1A-MEDIATED, C17-1A-MEDIATED AND CSF25-MEDIATED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY IN PATIENTS WITH ADVANCED CANCER. 70:753-758. 1994
- THYROID-DYSFUNCTION CAN PREDICT RESPONSE TO IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-2-ALPHA. 64:915-918. 1991
Research
category
- ONCOLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 0007-0920
Electronic International Standard Serial Number (EISSN)
- 1532-1827
Other
journal abbreviation
- BRIT J CANCER